NSE · TATVA
Tatva Chintan Pharma Chem Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#904
of 5,004 stocks
🏆 New peak
▲ 71W
Peak #904 · 01 Oct 2026
Tatva Chintan Pharma Chem Limited, a smallcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 72%.
Market Cap
4,173.60 Cr
P/E Ratio
99.23
P/B Ratio
5.34
ROE
5.38%
ROCE
7.57%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 167.06 Cr | 134.14 Cr | 131.33 Cr | 123.52 Cr |
| Net Profit | 15.98 Cr | 10.32 Cr | 15.16 Cr | 9.92 Cr |
| EPS | 6.83 | 4.41 | 6.49 | 4.24 |
| Operating Profit | 24.51 Cr | 18.02 Cr | 18.15 Cr | 14.17 Cr |
Shareholding pattern
Promoter
72.02%
Public
27.98%
Mutual fund holdings
₹108.71
Cr total
6
Schemes
5
Fund Houses
₹108.71 Cr
Total Exposure
Nippon India Mutual Fund₹84.05 Cr (77.3%)
ICICI Prudential Mutual Fund₹20.14 Cr (18.5%)
WhiteOak Capital Mutual Fund₹3.51 Cr (3.2%)
JM Financial Mutual Fund₹1.01 Cr (0.9%)
Motilal Oswal Mutual Fund₹0.00 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Sep 2025 | Dividend | Dividend - Re 1 Per Share |
| 06 Sep 2024 | Dividend | Dividend - Rs 2 Per Share |
| 06 Sep 2024 | Other | Annual General Meeting |
| 08 Sep 2023 | Other | Annual General Meeting |
| 08 Sep 2023 | Dividend | Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.